Home › NDC Lookup › RxCUI directory › RxCUI 2268044

4 ML bevacizumab-bvzr 25 MG/ML Injection [Zirabev] — RxCUI 2268044

RxNorm drug concept · Semantic branded drug
RxCUI 2268044 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2268044
Official name4 ML bevacizumab-bvzr 25 MG/ML Injection [Zirabev]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZirabev 100 MG per 4 ML Injection; Zirabev 100 MG in 4 ML Injection; Zirabev 25 MG/ML per 4 ML Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)12,465 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bevacizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Bevacizumab works by blocking a protein called VEGF, which tumors use to grow new blood vessels. Without that blood supply, the tumor has a harder time getting the nutrients it nee...
  • What exactly does bevacizumab do, and why am I getting it?
  • Bevacizumab is given through an IV — directly into a vein — by a nurse or infusion specialist at a clinic or cancer center. Your first infusion runs slowly over 90 minutes so the t...
  • How is it given, and how long does each infusion take?
📖 Read our full Bevacizumab Injection guide →

🕸️ Concept Web — How 4 ML bevacizumab-bvzr 25 MG/ML Injection [Zirabe... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 4 ML bevacizumab-bvzr 25 MG/ML Injection [Zirabev] RxCUI 2268044

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Bevacizumab 253337
    • Bevacizumab-bvzr 2268037
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zirabev 2268040
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bevacizumab Injection 1657065
    • Bevacizumab-bvzr Injection 2646576
    • Bevacizumab Injectable Product 1161185
    • Bevacizumab-bvzr Injectable Product 2663568
    • Bevacizumab Injection [Zirabev] 2268042
    • Bevacizumab-bvzr Injection [Zirabev] 2658120
    • Zirabev Injectable Product 2268043
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 4 ML bevacizumab-bvzr 25 MG/ML Injection SCD · 2268039
  • Bevacizumab-bvzr 25 MG/ML SCDC · 2268038
  • Bevacizumab Injection SCDF · 1657065
  • Bevacizumab-bvzr Injection SCDFP · 2646576
  • Bevacizumab Injectable Product SCDG · 1161185
  • Bevacizumab-bvzr Injectable Product SCDGP · 2663568

Brand-Name Concepts

  • Bevacizumab-bvzr 25 MG/ML [Zirabev] SBDC · 2268041
  • Bevacizumab Injection [Zirabev] SBDF · 2268042
  • Bevacizumab-bvzr Injection [Zirabev] SBDFP · 2658120
  • Zirabev Injectable Product SBDG · 2268043
  • Zirabev BN · 2268040

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2268044 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0315-01 1 VIAL, SINGLE-USE in 1 CARTON (0069-0315-01) / 4 mL in 1 V... Zirabev Pfizer Laboratories Div Pfizer Inc 2020-01-13
00069-0342-01 1 VIAL, SINGLE-USE in 1 CARTON (0069-0342-01) / 16 mL in 1... Zirabev Pfizer Laboratories Div Pfizer Inc 2020-01-13
Observed labelers: Pfizer Laboratories Div Pfizer Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q5118 Inj., zirabev, 10 mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.